Keyuan Pharmaceutical Keyuan Pharmaceutical
  • Home

  • About Us

      About Us
      • Company Profile

      • Corporate Culture

      • Honor

      • Development History

      • Quality Policy

      • Keyuan Pharmaceutical

      • Strategic Layout

      • ESG report

      • Research Institute Introduction

      About Us
  • Digital Manufacturing

      Digital Manufacturing
      • Factory Introduction

      • Production Capacity Introduction

      • Production Equipment Introduction

      • Device detection introduction

      • Intelligent Manufacturing Project

      Digital Manufacturing
  • Service

      Service
      • Raw material API CMO/CDMO business

      • Pharmaceutical CMO/CDMO business

      • Medical beauty material CMO/CDMO business

      • Featured pilot platform

      Service
  • Technology

      Technology
      • Nitration reaction technology

      • Hydrogenation reaction technology

      • Sulfonation reaction technology

      • Fluorination reaction technology

      • Chiral catalysis technology

      • Enzyme catalysis technology

      • Continuous flow technology

      • Featured pilot platform

      Technology
  • Products

      Products
      • Active Pharmaceutical Ingredient

      • Cosmetics raw materials

      • Medical beauty materials

      • Food additives

      • Pharmaceutical intermediates

      Products
  • News

      News
      • Keyuan News

      • Video

      News
  • Investor Relations

      Investor Relations
      • Investor Relations Management System

      • Investor Relations Activity Record

      • Listing Announcement

      Investor Relations
  • Contact Us

      Contact Us
      The company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
      • Leave a message online

      • Business hotline

      • Join us

      Contact Us
  • 中文

Stock Code: 301281
Confirm
3-in-1

3-in-1

Continuous flow

Continuous flow

Isosorbide mononitrate

Isosorbide mononitrate

Isosorbide mononitrate, lactose diluted

Isosorbide mononitrate, lactose diluted

Isosorbide dinitrate

Isosorbide dinitrate

Isosorbide dinitrate, lactose diluted

Isosorbide dinitrate, lactose diluted

Mecobalamin

Mecobalamin

Lansoprazole

Lansoprazole

Ropivacaine hydrochloride

Ropivacaine hydrochloride

Clarithromycin L-lactate

Clarithromycin L-lactate

Isoflurane (Forane)

Fluoxetine hydrochloride

Fluoxetine hydrochloride

Chlorpheniramine maleate

Chlorpheniramine maleate

Isoproterenol hydrochloride

Isoproterenol hydrochloride

Esmolol hydrochloride

Esmolol hydrochloride

Nicotinamide-tinidazole

Nicotinamide-tinidazole

< 1...5678 >

Phone

9

Phone

Phone

+86-531-88729272

E-Mail

8

E-Mail

E-Mail

public@keyuanpharm.com

Phone

9

Phone

Phone

+86-531-88729272

E-Mail

8

E-Mail

E-Mail

public@keyuanpharm.com

  • Home

  • About Us

    • Company Profile

    • Corporate Culture

    • Honor

    • Development History

    • Quality Policy

    • Keyuan Pharmaceutical

    • Strategic Layout

    • ESG report

    • Research Institute Introduction

  • Digital Manufacturing

    • Factory Introduction

    • Production Capacity Introduction

    • Production Equipment Introduction

    • Device detection introduction

    • Intelligent Manufacturing Project

  • Service

    • Raw material API CMO/CDMO business

    • Pharmaceutical CMO/CDMO business

    • Medical beauty material CMO/CDMO business

    • Featured pilot platform

  • Technology

    • Nitration reaction technology

    • Hydrogenation reaction technology

    • Sulfonation reaction technology

    • Fluorination reaction technology

    • Chiral catalysis technology

    • Enzyme catalysis technology

    • Continuous flow technology

    • Featured pilot platform

  • Products

    • Active Pharmaceutical Ingredient

    • Cosmetics raw materials

    • Medical beauty materials

    • Food additives

    • Pharmaceutical intermediates

  • News

    • Keyuan News

    • Video

  • Investor Relations

    • Investor Relations Management System

    • Investor Relations Activity Record

    • Listing Announcement

  • Contact Us

    • Leave a message online

    • Business hotline

    • Join us

  • 中文

Keyuan Pharmaceutical

Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province

Free Service Hotline

+86-531-88729272

public@keyuanpharm.com

Business License

Website Construction: Zhongqi Power Jinan | SEO Tags